Recon: Sanofi in talks to sell its consumer business Opella; Novo’s Rybelsus cut heart risks in Phase III trial
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States